SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
SIOX
Delisted
SIOX was delisted on the 22nd of March, 2023.
81 hedge funds and large institutions have $323M invested in Sio Gene Therapies Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+11
Holders Change %
+15.71%
% of All Funds
2.16%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.11%
New
16
Increased
37
Reduced
15
Closed
5
Calls
$535K
Puts
$276K
Net Calls
+$259K
Net Calls Change
+$168K
Top Buyers
| 1 |
ZBI
Ziff Brothers Investments
New York
|
+$12.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.98M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$7.38M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.58M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.02M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$53.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.77M |
| 3 |
DAM
Deltec Asset Management
New York
|
-$288K |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$271K |
| 5 |
Primecap Management
Pasadena,
California
|
-$259K |
